Gentiva Health Services (GTIV)
by Zacks Equity ResearchNovember 16, 2011 | Comments : 0 Recommended this article: (0)
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
Ratings downgrade and legal trouble were the other downsides. Overall, the future outlook for Gentiva does not look very promising.
Our six-month target price of $5.00 equates to 3.0x our earnings estimate for 2011. This price target implies an expected total negative return of 7.9% over that period. This is consistent with our Underperform recommendation on the shares.
Please login to Zacks.com or register to post a comment.